MyoPax Denmark ApS: Financial statements 2023
CVR: 43078046
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
MyoPax Denmark ApS (CVR 43078046) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -4,852,720 and a net result of DKK -5,320,286 compared with DKK -1,987,861 the year before. Equity in the 2023 report amounted to DKK -7,268,147. The company had 2 employees in the financial year.
- Gross Profit
- DKK -4,852,720
- Profit/Loss
- DKK -5,320,286
- Equity
- DKK -7,268,147
- Total Assets
- DKK 3,351,111
- Employees
- 2
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | -4.9M | -5.3M | -7.3M | 2 |
| 2022 | - | -1.8M | -2M | -1.9M | 1 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
MyoPax Denmark ApS has published its interim report for the period February 22, 2022 to December 31, 2022.
About MyoPax Denmark ApS
MyoPax Denmark ApS is a Danish company of the type Anpartsselskab based in København N, founded in 2022. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named KR 1974 ApS. The management consists of Verena Jennifer Johanna Schöwel-Wolf. The board consists of Simone Spuler and Verena Jennifer Johanna Schöwel-Wolf. The company is owned by MyoPax GmbH. The company has 1 employee (2024). In 2025, the company reported a gross profit of DKK -286,390 and a net result of DKK -833,247 compared with DKK -1,869,338 the year before. Equity in the 2025 report amounted to DKK -9,970,731.